BACKGROUND AND AIMS
Modern genetic testing in hypertrophic cardiomyopathy (HCM) includes newly described HCM-associated genes and full intronic regions of certain classic sarcomeric genes. This study evaluated genetic retesting in HCM patients with a prior negative test and identified predictors of a positive result to...
Daniel de Castro, Juan Pablo Ochoa, A. Fernández-Ávila et al.· European Heart Journal· 0 citations
BACKGROUND
MYBPC3 truncating variants (MYBPC3tv) represent the most common genetic substrate in hypertrophic cardiomyopathy, yet carriers show substantial phenotypic variability despite a shared mechanism of haploinsufficiency. The contribution of additional genetic variants to this variability remains incompletely def...
S. Garcia-Hernandez, L. de la Higuera Romero, J. Larrañaga-Moreira et al.· Circulation Genomic and Prec...· 0 citations
BACKGROUND
Family screening is recommended in dilated cardiomyopathy (DCM), but risk stratification of relatives of probands without pathogenic or likely pathogenic variants (gene-elusive) remains uncertain.
OBJECTIVES
This study sought to define the incidence, prognosis, and predictors of disease development in firs...
A. Paldino, E. Del Mestre, I. Gandin et al.· JACC. Heart failure· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.